Latest filing published 24 Sept 2026 for Theravance Biopharma, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Susannah Gray span 2 companies, the busiest being Theravance Biopharma, Inc. and Maravai Lifesciences Holdings, Inc. The record holds 11 filings, for trades running from 19 November 2021 to 23 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 24 September 2026: a transaction, in Theravance Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations